Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study-Reference-Cited by-同舟云学术

Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study

Published:2020-05 Issue:5 Volume:77 Page:563-572
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Lin Daniel W.,Shih Mei-Chiung^ORCID,Aronson William,Basler Joseph,Beer Tomasz M.,Brophy Mary,Cooperberg Matthew,Garzotto Mark,Kelly W. Kevin,Lee Kelvin,McGuire Valerie,Wang Yajie,Lu Ying,Markle Vivian,Nseyo Unyime,Ringer Robert,Savage Stephen J.^ORCID,Sinnott Patricia,Uchio Edward,Yang Claire C.^ORCID,Montgomery R. Bruce

Funder

Department of Veterans Affairs, Cooperative Studies Program

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer;Petrovich;BJU Int,2002

2. The specific definition of high risk prostate cancer has minimal impact on biochemical relapse-free survival;Nguyen;J Urol,2009

3. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results;Roehl;J Urol,2004

4. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy;D’Amico;N Engl J Med,2004

5. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer;Messing;N Engl J Med,1999

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Staging Intensification Strategies Associated with Radical Prostatectomy for High-Risk Prostate Cancer: Efficacy Evaluation and Exploration of Novel Approaches;Cancers;2024-07-05

2. Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable‐risk prostate cancer patients receiving docetaxel: Insights from a randomized trial;Cancer;2024-03

3. Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer;Current Treatment Options in Oncology;2024-01

4. Novel Approaches in the Systemic Management of High-Risk Prostate Cancer;Clinical Genitourinary Cancer;2023-12

5. Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels;JAMA Network Open;2023-11-01